CareDx to Acquire Naveris, Expanding Leadership in Viral-Driven Cancer MRD Surveillance Testing CareDx, Inc., widely recognized for its focus on advancing precision medicine solutions in transplant care, has taken a significant strategic step to broaden its reach into oncology diagnostics.…
Global Healthy Living Foundation to Integrate Walgreens Vaccine Scheduler, Enhancing Patient Access and Transparency The Global Healthy Living Foundation (GHLF) has announced a new collaboration with Walgreens aimed at simplifying how adults across the United States access vaccines. At the…
AIDS Healthcare Foundation Files Shareholder Proposal Urging Gilead Sciences to Increase Transparency on Patent Exclusivity Practices Access to life-saving medicines remains one of the most critical challenges in global healthcare, and for many advocates, the issue extends far beyond scientific…
Prothena Reports U.S. Food and Drug Administration Grants Fast Track Status to Coramitug (PRX004) for ATTR Cardiomyopathy, Secured by Novo Nordisk Prothena Corporation plc has announced a key regulatory development for coramitug, an investigational therapy being advanced for the treatment…
Evofem Signs Exclusive Deal to Distribute and Commercialize SOLOSEC Across Sub-Saharan Africa Evofem Biosciences, Inc., a biopharmaceutical company focused on advancing innovative solutions for women’s health, has announced a strategic step to expand global access to its flagship anti-infective therapy.…
Sun Pharma Enters Definitive Agreement to Acquire Organon Sun Pharmaceutical Industries Limited and Organon & Co. have entered into a definitive agreement that marks one of the most significant consolidation moves in the global pharmaceutical sector in recent years. Under…
WuXi Biologics’ Chengdu Microbial Manufacturing Facility Reaches Structural Completion with Key Equipment Installed WuXi Biologics has reached a major construction milestone in its global manufacturing expansion strategy, announcing the structural completion of its new microbial commercial manufacturing facility in Chengdu,…
Bristol Myers Squibb and Pfizer Partner with Mark Cuban Cost Plus Drug Company to Expand Access to Eliquis® (apixaban) The longstanding alliance between Bristol Myers Squibb and Pfizer has announced a notable expansion of its patient access strategy through a…
Anaxiom Reports Initial First-in-Human Clinical Results for Novel Minimally Invasive Obesity Device, Progresses Toward U.S. Early Feasibility Study Anaxiom Corporation, a clinical-stage innovator focused on developing minimally invasive solutions for obesity treatment, has announced the successful completion of a 12-patient…
GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial of Manganese-Based MRI Contrast Agent Under FDA Fast Track Status, Advancing Imaging Innovation Pipeline GE HealthCare has announced a major clinical milestone with the dosing of the first patient in…
Merz Group Participates in the “Made for Germany” Initiative The Merz Group has taken a significant step in reinforcing its commitment to Germany’s industrial and economic future by joining the “Made for Germany” initiative, a prominent alliance of 129 leading…
Late-Breaking PRESERVE Trial Findings Assess XVIVO’s HOPE Preservation Strategy in Heart Transplantation XVIVO, a global medical technology company specializing in organ preservation and transplantation, has announced encouraging late-breaking preliminary results from its PRESERVE Trial (NCT05881278). The study evaluates hypothermic oxygenated…